In order to ensure the best market practices, combined with improvements to corporate governance, the company has an area dedicated to Corporate Integrity, which encompasses Compliance, Risk Management and Internal Audit. It reports directly to the Ethics Committee, which is directly linked to the company’s presidency.

Click here and check out our Annual Compliance Report.

Annual Compliance Report (base year 2023)

The Ethics Committee is responsible for receiving occurrences from the various communication channels, conducting analyses and appropriately forwarding the facts. It holds weekly meetings, which confirms the major importance of this issue at Eurofarma.

The Corporate Integrity area reports to this committee, which discusses the seriousness of the occurrences and actions to be taken to mitigate the associated risks.

The results of internal audits are also presented and discussed to better address the actions. This body also observes whether the areas are acting according to the recommended implementations.

Ethics and Conduct

This publication expresses our Values, Mission and Objectives, which will be achieved from an ethical and transparent position. It summarizes the daily attitudes and behaviors that the company expects from each employee when dealing with colleagues, staff, suppliers, customers, the community and society. All employees, including international operations, receive specific training on the Code of Ethics and Conduct, which must be followed by everyone in the company and also serves as a reference for business partners.

Click here to read the Code of Ethics and Conduct in its entirety, understand and use this document as a reference in daily contact with Eurofarma.

Supplier Code of Ethics and Conduct

The Supplier Code of Ethics and Conduct establishes guidelines that must be followed by suppliers to ensure that their actions are in accordance with company values. The Code assists competent areas in conducting audits and contributes to ensuring that partners follow good organizational practices as well.

Eurofarma believes this is the best way to maintain ethical and sustainable relations.

Key topics of the Code:

• Labor Rights
• Health and Safety
• Socio-environmental Responsibility
• Business Integrity
• Confidentiality of Intellectual Property

Click here to access the Supplier Code of Ethics and Conduct.

The purpose of our Board of Directors is to support and evaluate the company’s strategic decisions. It is comprised of independent business leaders with varied backgrounds, enabling them to provide the company an unbiased, objective and rational view of the business.

In addition to the company’s president, the committee consists of six independent members who meet monthly.

Claudio Roberto Ely
A Civil Engineer who graduated from Universidade Federal do Rio Grande do Sul, he has over 40 years of experience in leading major organizations. He was in charge of companies in the hydroelectric and financial sectors and has extensive experience in the retail pharmaceutical industry.

Cristina Palmaka

In 2019, Cristina assumed the Presidency of SAP for Latin America and the Caribbean. From 2013 to 2019, she served as president of SAP Brasil, one of the most important subsidiaries of the global company. Cristina has extensive professional experience focusing on innovation and technologies in the Brazilian IT industry. She acts as a corporate governance agent, ensuring its proper functioning, aiming at achieving growth in sustainability and collaborating with the Board for its future decisions. Cristina promotes equality and diversity in the corporate environment, articulating strong integration between teams.

Juliana Rozenbaum
Juliana has a degree in Economics and the CFA® designation, in addition to extensive experience in the consumer and retail sector. She is a member of the Board of Directors for Lojas Renner and Arezzo&Co, and an independent member of the Board of Directors for Duratex S.A. and EDP, Energias do Brasil S.A. She also participates in several Committees within these companies. In addition to Eurofarma, she is an advisory board member for GoCase and Uatt – Endeavor entrepreneurial companies.

Marcelo Martins
Marcelo Martins has been Vice President of Finance and Investor Relations at Cosan Limited since April 2015. With a bachelor’s in Business Administration from Fundação Getúlio Vargas (FGV) and specializing in finance, Martins is a member of the Board of Directors for Cosan Limited, Cosan S.A, Rumo ALL, Comgás, Cosan Logística, Rumo Logística and Radar. He also participates in the Boards for Fundação Bienal, MASP and the Museu Reina Sofia in Madrid. He joined Cosan in July 2007 as an executive of Aguassanta Participações S.A. and was Vice President of Finance and Investor Relations for Cosan S.A from 2009 to 2015. Prior to working for Cosan, he was Financial and Business Development Officer for Votorantim Cimentos from 2003 to 2007. He also headed the Latin American Fixed Income department for Salomon Smith Barney in New York.

Nelson Mussolini
Nelson is an attorney with over 30 years of experience in the pharmaceutical industry. His experience goes beyond the legal field, including finance and HR. He has already participated in merger processes and always maintained the activity along with the class associations. He is currently executive president of Sindusfarma – Industry Syndicate of Pharmaceutical Products in the State of São Paulo.

Julio Cesar Gagliardi

Julio Cesar Gagliardi entered Eurofarma in 2001, assuming the Commercial area. Since 2008 he acted as the Vice President of the Commercial area, commanding the business units of Medical Prescription, Generics, Oncology, Hospital and Bids. In July of 2023, Mr. Julio is no longer an employee of Eurofarma and is now a consultant and a member for Eurofarma's Board of Directors.

Eurofarma Ethics Channel is an independent and confidential platform for reporting events and behaviors that do not comply with the Code of Ethics and Conduct. It can be used by employees, suppliers, and the general public.

This channel is managed by an external company, which ensures data confidentiality and protects the identity of whistleblowers, if requested. The analysis and investigation of reports are conducted by the Corporate Integrity area, which reports to the Ethics Committee, directly linked to the Presidency.

The Eurofarma Ethics Channel helps mitigate risks to the company. It is a tool that offers confidentiality, anonymity, and discretion in handling investigations, helping reduce the impact of unfounded complaints and focusing on relevant matters.

In 2024, there were no cases of corruption involving public officials under the legal definition of the term. Additionally, no legal proceedings were registered involving Eurofarma or its employees during the year.

Reports are continuously evaluated to reinforce the proper use of the Channel. Reporting can be done through the official website of the Eurofarma Ethics Channel or via the contact information below:

Phone line (Brazil only): 0800 741 0022
WhatsApp (Global use): 0800 741 0022

Eurofarma conducts its business according to the highest ethical and moral standards set out in its Code of Ethics and Conduct, not tolerating any form of corruption and bribery. We are committed to conducting our operations in strict compliance with all applicable laws, including anti-corruption legislation (including Law 12.846/13) and other standards governing our relationship with public and private administration.

In 2017, the Code of Ethics and Conduct was updated with specific policies on Fighting Corruption and Healthcare Professional Relationships, as required by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Code and Interfarma Code of Conduct. Regulated terms include sponsorship of professionals and events and free sample distribution.

The Anti-Corruption Policy lists the guidelines, standards and procedures that aim to ensure that Eurofarma – and all those acting on its behalf – understand and act in accordance with applicable anti-corruption laws in all dealings with public administration or public officials, as well as in dealings with the private sector.

Click here to see the full document (in portuguese).